Laboratory Solutions for I-O and CDx Development

A podcast series on I-O clinical development testing

In our Immuno-Oncology podcast series, Q2 Solutions scientists and subject matter experts discuss our innovative immunotherapy laboratory services that combine scientific expertise, innovative technologies, and industry relationships. Check every Tuesday for a new episode. Listen on Apple Podcasts or Stitcher.

Episode 6

Episode 5

Episode 4

Episode 3

Episode 2

Episode 1

Q2 Solutions is a premier global clinical trial laboratory service provider for Immuno-Oncology (IO) clinical development testing. We have a global laboratory network with a footprint in the Americas, Europe, Asia-Pacific, and China, and we offer a breadth of technological expertise and harmonized processes across our laboratories.

Learn more about our integrated Immuno-Oncology solutions.
T-cell Receptor (TCR) Sequencing Assay for Characterization of Adaptive Immune Response

Detects TCRβ and TCRγ clonotypes expressed at the mRNA level

Microsatellite Instability Assay for Response to Immunotherapy

MSI assay for sensitive detection of 5 mononucleotide repeat markers in tumor FFPE specimens

Read More